Nacuity Pharmaceuticals Announces First Patients Implanted in Final Cohort of Phase 1/2 Clinical Trial Evaluating NPI-002 Intravitreal Implant for the Delay of Cataract Progression
30 avr. 2024 09h00 HE
|
Nacuity Pharmaceuticals, Inc.
Two patients have been implanted in the final cohort of the trial Final cohort is actively enrolling adult patients undergoing vitrectomy FORT WORTH, Texas, April 30, 2024 (GLOBE NEWSWIRE) --...
SpyGlass Pharma Strengthens Leadership to Further Advance its Intraocular Drug Delivery Platform
05 déc. 2023 09h00 HE
|
SpyGlass Pharma, Inc.
Margot Goodkin, M.D., Ph.D., appointed Chief Medical OfficerBilal Khan, MBA, CEO of New World Medical, appointed to the SpyGlass Board of Directors ALISO VIEJO, Calif., Dec. 05, 2023 (GLOBE...
SpyGlass Pharma Initiates Phase I/II Clinical Trial of its Intraocular Drug Delivery Platform
31 oct. 2023 07h00 HE
|
SpyGlass Pharma, Inc.
ALISO VIEJO, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately-held ophthalmic biotechnology company, announced today the initiation of a Phase I/II clinical trial...
Nacuity Pharmaceuticals Advances Phase 1/2 Clinical Trial Evaluating NPI-002 Intravitreal Implant for the Delay of Cataract Progression
11 juil. 2023 09h00 HE
|
Nacuity Pharmaceuticals, Inc.
New clinical site added and early safety signals observed in trial for treatment of ocular disease caused by oxidative stress First cohort is expected to achieve full enrollment by third quarter...
Vision Care Market Share Report ($98.96 Billion by 2028) Lead by Eyeglasses Segment - Exclusive Report by The Insight Partners
28 févr. 2023 08h25 HE
|
The Insight Partners
New York, Feb. 28, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Vision Care Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis By...
Harvard Eye Associates is the First to Implant the New IC-8® Apthera™ Intraocular Lens in Orange County, CA
06 févr. 2023 14h00 HE
|
Harvard Eye Associates
LAGUNA HILLS, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Harvard Eye Associates, a multi-specialty ophthalmology practice, implanted the first IC-8® Apthera™ intraocular lens (IOL) in Orange County,...
Coastal Vision Medical Group Opens New Location in Chino, CA
21 avr. 2022 11h00 HE
|
Coastal Vision Medical Group
CHINO, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Coastal Vision Medical Group, a premier multi-location ophthalmology practice specializing in cataract and LASIK surgery, has opened a new...
National Coalition Launches new scEYEnce Campaign
09 sept. 2020 09h00 HE
|
scEYEnce
—Effort points to the vital importance of vision research, how it is improving sight and broader health and well-being—NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- A national coalition of 10 leading...
HelpMeSee Partners with TransPerfect in Global Campaign to End Cataract Blindness
20 avr. 2016 10h04 HE
|
TransPerfect
NEW YORK, April 20, 2016 (GLOBE NEWSWIRE) -- TransPerfect, the world's largest privately held provider of language services and technology solutions, today announced a partnership with HelpMeSee,...
Washington Eye Doctors Reveal Tips for Best Summer Sun Protection
05 juin 2014 09h03 HE
|
North Cascade Eye Associates
MT. VERNON, WA--(Marketwired - Jun 5, 2014) - The eye doctors at North Cascade Eye Associates pride themselves on their commitment to continually improving and protecting the vision of their...